Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Evolus appoints Crystal Muilenburg to CMO » 09:04
02/26/21
02/26
09:04
02/26/21
09:04
EOLS

Evolus

$11.53 /

+0.09 (+0.79%)

Evolus announced the…

Evolus announced the promotion of Crystal Muilenburg from VP, Corporate Communications & PR to CMO. Crystal will oversee the U.S. marketing organization and establish the company's international infrastructure to support the expansion of Nuceiva in all Evolus licensed territories. Crystal has more than two decades of marketing and communications experience, with more than a decade in aesthetics. In her last role at Allergan, she established and led the International Plastic Surgery & Body Contouring marketing team, and successfully integrated and launched new aesthetics products in Europe, Canada and Australia. Also announced, Michael Mazen Jafar will depart Evolus on February 26 to lead a health technology organization. Michael previously led the marketing and sales organization as CCO.

ShowHide Related Items >><<
EOLS Evolus
$11.53 /

+0.09 (+0.79%)

EOLS Evolus
$11.53 /

+0.09 (+0.79%)

02/24/21 Truist
Evolus downgraded to Hold from Buy at Truist
02/24/21 Truist
Evolus downgraded to Hold from Buy at Truist
02/22/21 Barclays
Evolus price target raised to $8 from $4 at Barclays
02/22/21 Cantor Fitzgerald
Evolus price target raised to $20 from $11 at Cantor Fitzgerald
EOLS Evolus
$11.53 /

+0.09 (+0.79%)

EOLS Evolus
$11.53 /

+0.09 (+0.79%)

EOLS Evolus
$11.53 /

+0.09 (+0.79%)

EOLS Evolus
$11.53 /

+0.09 (+0.79%)

Recommendations
Twitter price target raised to $79 from $64 at Jefferies » 04:59
02/26/21
02/26
04:59
02/26/21
04:59
TWTR

Twitter

$74.55 /

+2.64 (+3.67%)

, FB

Facebook

$254.66 /

-9.68 (-3.66%)

Jefferies analyst Brent…

Jefferies analyst Brent Thill raised the firm's price target on Twitter (TWTR) to $79 from $64 and keeps a Hold rating on the shares. Twitter's analyst day will "fuel the bull case for the stock" with management guiding to 26% annual revenue growth through 2023, the fastest three-year growth period in five years, Thill tells investors in a research note. He believes there is a "long runway for growth" at Twitter. However, with the stock trading at all-time highs versus Facebook (FB) the risk/reward is less attractive, says Thill.

ShowHide Related Items >><<
TWTR Twitter
$74.55 /

+2.64 (+3.67%)

FB Facebook
$254.66 /

-9.68 (-3.66%)

TWTR Twitter
$74.55 /

+2.64 (+3.67%)

02/26/21 Pivotal Research
Twitter price target raised to $95 from $77.25 at Pivotal Research
02/25/21 KeyBanc
KeyBanc says Twitter guide reinforces view that Street understating improvement
02/25/21 BMO Capital
Twitter price target raised to $75 from $45 at BMO Capital
02/22/21 Baird
Twitter price target raised to $75 from $65 at Baird
FB Facebook
$254.66 /

-9.68 (-3.66%)

02/16/21 Loop Capital
Facebook price target raised to $370 from $330 at Loop Capital
02/10/21 Tigress Financial
Facebook has 'significant upside' at current levels, says Tigress
02/01/21 Truist
Alphabet price target raised to $2,100 from $2,000 at Truist
01/31/21 Citi
Facebook price target raised to $320 from $315 at Citi
TWTR Twitter
$74.55 /

+2.64 (+3.67%)

FB Facebook
$254.66 /

-9.68 (-3.66%)

TWTR Twitter
$74.55 /

+2.64 (+3.67%)

FB Facebook
$254.66 /

-9.68 (-3.66%)

TWTR Twitter
$74.55 /

+2.64 (+3.67%)

FB Facebook
$254.66 /

-9.68 (-3.66%)

TWTR Twitter
$74.55 /

+2.64 (+3.67%)

FB Facebook
$254.66 /

-9.68 (-3.66%)

Thursday
Hot Stocks
AbbVie's Allergan submits NDA to FDA for investigational AGN-190584 » 08:04
02/25/21
02/25
08:04
02/25/21
08:04
ABBV

AbbVie

$108.68 /

+2.42 (+2.28%)

Allergan, an AbbVie…

Allergan, an AbbVie company, announced that it has submitted a New Drug Application to the U.S. FDA for investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia. The FDA is expected to act on the NDA by the end of 2021.

ShowHide Related Items >><<
ABBV AbbVie
$108.68 /

+2.42 (+2.28%)

ABBV AbbVie
$108.68 /

+2.42 (+2.28%)

02/24/21 Truist
Evolus downgraded to Hold from Buy at Truist
02/19/21 Stifel
Stifel raises Evolus price target to $25, calls settlement a 'win for all'
02/04/21 SVB Leerink
AbbVie price target raised to $140 from $128 at SVB Leerink
02/04/21
AbbVie price target raised to $135 from $129 at RBC Capital
ABBV AbbVie
$108.68 /

+2.42 (+2.28%)

ABBV AbbVie
$108.68 /

+2.42 (+2.28%)

ABBV AbbVie
$108.68 /

+2.42 (+2.28%)

ABBV AbbVie
$108.68 /

+2.42 (+2.28%)

Wednesday
Hot Stocks
AbbVie says FDA approves Humira to treat pediatric patients » 19:17
02/24/21
02/24
19:17
02/24/21
19:17
ABBV

AbbVie

$108.68 /

+2.42 (+2.28%)

AbbVie announced that the…

AbbVie announced that the U.S. Food and Drug Administration approved HUMIRA for the treatment of moderately to severely active ulcerative colitis in pediatric patients 5 years of age and older. In clinical trials, HUMIRA induced clinical remission at Week 8 and maintained remission at Week 52 in patients who responded at Week 8. "Ulcerative colitis can have a profound effect on children and for too long, treatment options for pediatric patients have been limited," said Brandee Pappalardo, vice president and head of U.S. immunology medical affairs, AbbVie. "This approval provides the first and only subcutaneous biologic for pediatric patients with ulcerative colitis that can be administered at home. This new indication for HUMIRA demonstrates AbbVie's commitment to patients with inflammatory bowel diseases and reinforces our goal of reducing the burden of this disease for patients."

ShowHide Related Items >><<
ABBV AbbVie
$108.68 /

+2.42 (+2.28%)

ABBV AbbVie
$108.68 /

+2.42 (+2.28%)

02/24/21 Truist
Evolus downgraded to Hold from Buy at Truist
02/19/21 Stifel
Stifel raises Evolus price target to $25, calls settlement a 'win for all'
02/04/21 SVB Leerink
AbbVie price target raised to $140 from $128 at SVB Leerink
02/04/21
AbbVie price target raised to $135 from $129 at RBC Capital
ABBV AbbVie
$108.68 /

+2.42 (+2.28%)

ABBV AbbVie
$108.68 /

+2.42 (+2.28%)

ABBV AbbVie
$108.68 /

+2.42 (+2.28%)

ABBV AbbVie
$108.68 /

+2.42 (+2.28%)

Periodicals
Facebook exploring potential media licensing agreements in Canada, Reuters says » 18:54
02/24/21
02/24
18:54
02/24/21
18:54
FB

Facebook

$264.45 /

-1.25 (-0.47%)

Facebook is looking into…

Facebook is looking into potential licensing deals in the coming year with Canadian media outlets and expanding its investment in local journalism initiatives, Reuters' Moira Warburton reports, citing a source familiar with the company's thinking. The move comes as Canada is getting ready to introduce legislation soon, along the lines of the Australian model that forces tech firms such as Facebook to pay media companies for content, the author says. The source told Reuters that Facebook considers the situation in Australia unique. Reference Link

ShowHide Related Items >><<
FB Facebook
$264.45 /

-1.25 (-0.47%)

FB Facebook
$264.45 /

-1.25 (-0.47%)

02/16/21 Loop Capital
Facebook price target raised to $370 from $330 at Loop Capital
02/10/21 Tigress Financial
Facebook has 'significant upside' at current levels, says Tigress
02/01/21 Truist
Alphabet price target raised to $2,100 from $2,000 at Truist
01/31/21 Citi
Facebook price target raised to $320 from $315 at Citi
FB Facebook
$264.45 /

-1.25 (-0.47%)

FB Facebook
$264.45 /

-1.25 (-0.47%)

FB Facebook
$264.45 /

-1.25 (-0.47%)

FB Facebook
$264.45 /

-1.25 (-0.47%)

On The Fly
#SocialStocks: Snap shares advance following first investor day » 15:55
02/24/21
02/24
15:55
02/24/21
15:55
GOOGL

Alphabet Class A

$2,087.37 /

+23.37 (+1.13%)

, GOOG

Alphabet

$2,097.53 /

+23.57 (+1.14%)

, TWTR

Twitter

$72.36 /

-0.82 (-1.12%)

, FB

Facebook

$265.65 /

-0.05 (-0.02%)

, SPT

Sprout Social

$76.20 /

+8.39 (+12.37%)

, SNAP

Snap

$69.94 /

-0.445 (-0.63%)

Welcome to…

ShowHide Related Items >><<
TWTR Twitter
$72.36 /

-0.82 (-1.12%)

SPT Sprout Social
$76.20 /

+8.39 (+12.37%)

SNAP Snap
$69.94 /

-0.445 (-0.63%)

GOOGL Alphabet Class A
$2,087.37 /

+23.37 (+1.13%)

FB Facebook
$265.65 /

-0.05 (-0.02%)

GOOGL Alphabet Class A
$2,087.37 /

+23.37 (+1.13%)

02/17/21 Maxim
Kaleyra price target raised to $30 from $22 at Maxim
02/17/21 Morgan Stanley
Roku price target raised to $275 from $200 at Morgan Stanley
02/16/21 Loop Capital
Alphabet upgraded to Buy from Hold at Loop Capital
02/12/21 Citi
Citi boosts Alphabet target but shares no longer a top pick
GOOG Alphabet
$2,097.53 /

+23.57 (+1.14%)

02/08/21 Stephens
Global Payments merchant business advanced by Google pact, says Stephens
02/03/21 JMP Securities
Alphabet price target raised to $2,400 from $1,700 at JMP Securities
TWTR Twitter
$72.36 /

-0.82 (-1.12%)

02/26/21 Stifel
Twitter price target raised to $70 from $60 at Stifel
02/26/21 JPMorgan
Twitter price target raised to $91 from $77 at JPMorgan
02/26/21 KeyBanc
Twitter price target raised to $90 from $80 at KeyBanc
02/26/21 Mizuho
Twitter price target raised to $67 from $57 at Mizuho
FB Facebook
$265.65 /

-0.05 (-0.02%)

02/26/21 Jefferies
Twitter price target raised to $79 from $64 at Jefferies
02/16/21 Loop Capital
Facebook price target raised to $370 from $330 at Loop Capital
02/10/21 Tigress Financial
Facebook has 'significant upside' at current levels, says Tigress
02/01/21 Truist
Alphabet price target raised to $2,100 from $2,000 at Truist
SPT Sprout Social
$76.20 /

+8.39 (+12.37%)

02/24/21 KeyBanc
Sprout Social price target raised to $81 from $55 at KeyBanc
02/24/21 Canaccord
Sprout Social price target raised to $77 from $50 at Canaccord
02/24/21 Morgan Stanley
Sprout Social price target raised to $81 from $53 at Morgan Stanley
02/24/21 Barclays
Sprout Social price target raised to $84 from $68 at Barclays
SNAP Snap
$69.94 /

-0.445 (-0.63%)

02/24/21 Evercore ISI
Snap price target raised to $75 from $57 at Evercore ISI
02/24/21 Cowen
Snap price target raised to $86 from $70 at Cowen
02/24/21 Credit Suisse
Snap price target raised to $80 from $65 at Credit Suisse
02/24/21 KeyBanc
Snap price target raised to $87 from $63 at KeyBanc
TWTR Twitter
$72.36 /

-0.82 (-1.12%)

SPT Sprout Social
$76.20 /

+8.39 (+12.37%)

SNAP Snap
$69.94 /

-0.445 (-0.63%)

GOOGL Alphabet Class A
$2,087.37 /

+23.37 (+1.13%)

GOOG Alphabet
$2,097.53 /

+23.57 (+1.14%)

FB Facebook
$265.65 /

-0.05 (-0.02%)

  • 13
    Aug
TWTR Twitter
$72.36 /

-0.82 (-1.12%)

SNAP Snap
$69.94 /

-0.445 (-0.63%)

GOOGL Alphabet Class A
$2,087.37 /

+23.37 (+1.13%)

FB Facebook
$265.65 /

-0.05 (-0.02%)

TWTR Twitter
$72.36 /

-0.82 (-1.12%)

SPT Sprout Social
$76.20 /

+8.39 (+12.37%)

SNAP Snap
$69.94 /

-0.445 (-0.63%)

GOOGL Alphabet Class A
$2,087.37 /

+23.37 (+1.13%)

FB Facebook
$265.65 /

-0.05 (-0.02%)

TWTR Twitter
$72.36 /

-0.82 (-1.12%)

SNAP Snap
$69.94 /

-0.445 (-0.63%)

GOOGL Alphabet Class A
$2,087.37 /

+23.37 (+1.13%)

GOOG Alphabet
$2,097.53 /

+23.57 (+1.14%)

FB Facebook
$265.65 /

-0.05 (-0.02%)

Downgrade
Evolus downgraded to Hold from Buy at Truist » 07:16
02/24/21
02/24
07:16
02/24/21
07:16
EOLS

Evolus

$9.87 /

-1.11 (-10.11%)

, ABBV

AbbVie

$106.26 /

-0.73 (-0.68%)

Truist analyst Gregg…

Truist analyst Gregg Gilbert downgraded Evolus (EOLS) to Hold from Buy with a higher price target of $12, up from $6. The company's settlement with Abbvie (ABBV) and Medytox to resolve the ITC dispute removed a major overhang, allowing it to focus on "building its brand" without the distraction of a "potentially crippling" outcome, the analyst tells investors in a research note. Following the settlement, the valuation on the stock has readjusted to a more fair value, Gilbert adds.

ShowHide Related Items >><<
EOLS Evolus
$9.87 /

-1.11 (-10.11%)

ABBV AbbVie
$106.26 /

-0.73 (-0.68%)

EOLS Evolus
$9.87 /

-1.11 (-10.11%)

02/24/21 Truist
Evolus downgraded to Hold from Buy at Truist
02/22/21 Barclays
Evolus price target raised to $8 from $4 at Barclays
02/22/21 Cantor Fitzgerald
Evolus price target raised to $20 from $11 at Cantor Fitzgerald
02/22/21 Mizuho
Evolus price target raised to $9 from $5 at Mizuho
ABBV AbbVie
$106.26 /

-0.73 (-0.68%)

02/19/21 Stifel
Stifel raises Evolus price target to $25, calls settlement a 'win for all'
02/04/21 SVB Leerink
AbbVie price target raised to $140 from $128 at SVB Leerink
02/04/21
AbbVie price target raised to $135 from $129 at RBC Capital
02/04/21
AbbVie price target raised to $126 from $117 at Mizuho
EOLS Evolus
$9.87 /

-1.11 (-10.11%)

ABBV AbbVie
$106.26 /

-0.73 (-0.68%)

EOLS Evolus
$9.87 /

-1.11 (-10.11%)

ABBV AbbVie
$106.26 /

-0.73 (-0.68%)

EOLS Evolus
$9.87 /

-1.11 (-10.11%)

ABBV AbbVie
$106.26 /

-0.73 (-0.68%)

EOLS Evolus
$9.87 /

-1.11 (-10.11%)

ABBV AbbVie
$106.26 /

-0.73 (-0.68%)

Downgrade
Evolus downgraded to Hold from Buy at Truist » 06:39
02/24/21
02/24
06:39
02/24/21
06:39
EOLS

Evolus

$9.87 /

-1.11 (-10.11%)

Truist analyst Gregg…

Truist analyst Gregg Gilbert downgraded Evolus to Hold from Buy with a $12 price target.

ShowHide Related Items >><<
EOLS Evolus
$9.87 /

-1.11 (-10.11%)

EOLS Evolus
$9.87 /

-1.11 (-10.11%)

02/22/21 Barclays
Evolus price target raised to $8 from $4 at Barclays
02/22/21 Cantor Fitzgerald
Evolus price target raised to $20 from $11 at Cantor Fitzgerald
02/22/21 Mizuho
Evolus price target raised to $9 from $5 at Mizuho
02/22/21 H.C. Wainwright
Evolus price target raised to $18 from $6 at H.C. Wainwright
EOLS Evolus
$9.87 /

-1.11 (-10.11%)

EOLS Evolus
$9.87 /

-1.11 (-10.11%)

EOLS Evolus
$9.87 /

-1.11 (-10.11%)

EOLS Evolus
$9.87 /

-1.11 (-10.11%)

Tuesday
On The Fly
Fly Intel: Wall Street's top stories at midday » 12:17
02/23/21
02/23
12:17
02/23/21
12:17
HD

Home Depot

$262.96 /

-12.87 (-4.67%)

, M

Macy's

$15.53 /

+0.25 (+1.64%)

, CCIV

Churchill Capital Corp IV

$38.10 /

-19.3 (-33.62%)

, FB

Facebook

$262.57 /

+2.22 (+0.85%)

, AMC

AMC Entertainment

$7.56 /

+1.03 (+15.77%)

, FI

Frank's International

$4.35 /

+0.88 (+25.36%)

, ZI

ZoomInfo

$55.19 /

+3.875 (+7.55%)

, PAVM

PAVmed

$4.34 /

-1.2 (-21.66%)

, NLS

Nautilus

$22.00 /

-4.61 (-17.32%)

, SPR

Spirit AeroSystems

$41.85 /

-0.91 (-2.13%)

, PSTH

Pershing Square Tontine Holdings

$28.30 /

-1.15 (-3.90%)

, NKLA

Nikola

$19.19 /

-1.72 (-8.23%)

, FSR

Fisker

$16.50 /

-1.65 (-9.09%)

, BFT

Foley Trasimene Acquisition Corp. II

$15.78 /

-1.14 (-6.74%)

, FTOC

FTAC Olympus Acquisition

$11.80 /

-0.8 (-6.35%)

, RTP

Reinvent Technology Partners

$13.10 /

-1.52 (-10.40%)

, CIIC

CIIG Merger

$23.60 /

-2.54 (-9.72%)

, SBEI

SBE Inc

$0.00 /

+ (+0.00%)

, FIII

Forum Merger III

$10.65 /

-0.74 (-6.50%)

, BOX

Box

$18.53 /

+0.925 (+5.25%)

, LH

LabCorp

$248.44 /

+4.32 (+1.77%)

The major averages are…

ShowHide Related Items >><<
ZI ZoomInfo
$55.19 /

+3.875 (+7.55%)

SPR Spirit AeroSystems
$41.85 /

-0.91 (-2.13%)

PSTH Pershing Square Tontine Holdings
$28.30 /

-1.15 (-3.90%)

PAVM PAVmed
$4.34 /

-1.2 (-21.66%)

NLS Nautilus
$22.00 /

-4.61 (-17.32%)

NKLA Nikola
$19.19 /

-1.72 (-8.23%)

M Macy's
$15.53 /

+0.25 (+1.64%)

LH LabCorp
$248.44 /

+4.32 (+1.77%)

HD Home Depot
$262.96 /

-12.87 (-4.67%)

FTOC FTAC Olympus Acquisition
$11.80 /

-0.8 (-6.35%)

FSR Fisker
$16.50 /

-1.65 (-9.09%)

FIII Forum Merger III
$10.65 /

-0.74 (-6.50%)

FI Frank's International
$4.35 /

+0.88 (+25.36%)

FB Facebook
$262.57 /

+2.22 (+0.85%)

CIIC CIIG Merger
$23.60 /

-2.54 (-9.72%)

CCIV Churchill Capital Corp IV
$38.10 /

-19.3 (-33.62%)

BOX Box
$18.53 /

+0.925 (+5.25%)

BFT Foley Trasimene Acquisition Corp. II
$15.78 /

-1.14 (-6.74%)

AMC AMC Entertainment
$7.56 /

+1.03 (+15.77%)

HD Home Depot
$262.96 /

-12.87 (-4.67%)

02/17/21 JPMorgan
JPMorgan boosts Home Depot, Lowe's Q4 comp estimates to Street high
02/12/21 Zelman
Home Depot upgraded to Buy from Hold at Zelman
01/13/21 Guggenheim
Guggenheim upgrades Home Depot to Buy on 'potentially conservative' expectations
01/13/21 Guggenheim
Home Depot upgraded to Buy from Neutral at Guggenheim
M Macy's
$15.53 /

+0.25 (+1.64%)

02/18/21 Morgan Stanley
Macy's price target raised to $11 from $6 at Morgan Stanley
01/21/21 Deutsche Bank
Macy's price target raised to $15 from $9 at Deutsche Bank
12/18/20 Jefferies
Macy's assumed with Buy from Hold at Jefferies
11/20/20 Deutsche Bank
Macy's price target raised to $9 from $7 at Deutsche Bank
CCIV Churchill Capital Corp IV
$38.10 /

-19.3 (-33.62%)

02/23/21 Wells Fargo
Trinity Capital initiated with an Overweight at Wells Fargo
FB Facebook
$262.57 /

+2.22 (+0.85%)

02/16/21 Loop Capital
Facebook price target raised to $370 from $330 at Loop Capital
02/10/21 Tigress Financial
Facebook has 'significant upside' at current levels, says Tigress
02/01/21 Truist
Alphabet price target raised to $2,100 from $2,000 at Truist
01/31/21 Citi
Facebook price target raised to $320 from $315 at Citi
AMC AMC Entertainment
$7.56 /

+1.03 (+15.77%)

02/04/21 Citi
Citi sees 'dramatically reduced' bankruptcy risk for AMC Entertainment
02/01/21 MKM Partners
AMC Entertainment downgraded to Sell from Neutral at MKM Partners
02/01/21 MKM Partners
AMC Entertainment downgraded to Sell from Neutral at MKM Partners
01/26/21 Loop Capital
AMC Entertainment's capital raise results in massive dilution, says Loop Capital
FI Frank's International
$4.35 /

+0.88 (+25.36%)

ZI ZoomInfo
$55.19 /

+3.875 (+7.55%)

02/23/21 Truist
ZoomInfo price target raised to $67 from $60 at Truist
02/23/21 Morgan Stanley
ZoomInfo price target raised to $72 from $55 at Morgan Stanley
02/23/21 Credit Suisse
ZoomInfo price target raised to $70 from $60 at Credit Suisse
02/23/21 Barclays
ZoomInfo price target raised to $57 from $49 at Barclays
PAVM PAVmed
$4.34 /

-1.2 (-21.66%)

02/22/21 Lake Street
PAVmed price target raised to $9 from $5 at Lake Street
11/05/20
Fly Intel: Top five analyst initiations
11/05/20 Ascendiant
Ascendiant starts PAVmed with Buy on carpal tunnel potential
11/05/20 Ascendiant
PAVmed initiated with a Buy at Ascendiant
NLS Nautilus
$22.00 /

-4.61 (-17.32%)

11/10/20 Lake Street
Nautilus price target raised to $40 from $30 at Lake Street
11/10/20 Craig-Hallum
Nautilus price target raised to $28 from $22 at Craig-Hallum
10/15/20 Lake Street
Nautilus price target raised to $30 from $17 at Lake Street
10/14/20 Truist
Nautilus price target raised to $28 from $18 at Truist
SPR Spirit AeroSystems
$41.85 /

-0.91 (-2.13%)

01/21/21
Fly Intel: Top five analyst upgrades
01/21/21 Credit Suisse
Spirit AeroSystems upgraded to Outperform from Neutral at Credit Suisse
01/21/21 Credit Suisse
Spirit AeroSystems upgraded to Outperform from Neutral at Credit Suisse
01/11/21 Baird
Baird bullish on aerospace stocks, upgrades Spirit AeroSystems
PSTH Pershing Square Tontine Holdings
$28.30 /

-1.15 (-3.90%)

NKLA Nikola
$19.19 /

-1.72 (-8.23%)

02/01/21
Fly Intel: Top five analyst upgrades
02/01/21 Wedbush
Nikola upgraded to Neutral from Underperform at Wedbush
12/28/20 JPMorgan
JPMorgan cuts Nikola target but sees 'generally positive' news flow in 2021
12/24/20 Loop Capital
Nikola faces 'another setback in a series of setbacks,' says Loop Capital
FSR Fisker
$16.50 /

-1.65 (-9.09%)

02/17/21 R.F. Lafferty
Fisker initiated with a Buy at R.F. Lafferty
02/11/21 Morgan Stanley
Fisker initiated with an Overweight at Morgan Stanley
01/21/21 Raymond James
Raymond James starts Fisker with Market Perform given 'crowded space'
01/21/21 Raymond James
Fisker initiated with a Market Perform at Raymond James
BFT Foley Trasimene Acquisition Corp. II
$15.78 /

-1.14 (-6.74%)

FTOC FTAC Olympus Acquisition
$11.80 /

-0.8 (-6.35%)

RTP Reinvent Technology Partners
$13.10 /

-1.52 (-10.40%)

CIIC CIIG Merger
$23.60 /

-2.54 (-9.72%)

01/14/21 Wolfe Research
CIIG Merger Corp initiated with an Outperform at Wolfe Research
SBEI SBE Inc
$0.00 /

+ (+0.00%)

FIII Forum Merger III
$10.65 /

-0.74 (-6.50%)

BOX Box
$18.53 /

+0.925 (+5.25%)

01/25/21
Fly Intel: Top five analyst downgrades
01/25/21 DA Davidson
Box downgraded to Neutral from Buy at DA Davidson
08/27/20 Craig-Hallum
Box price target raised to $30 from $24 at Craig-Hallum
08/27/20 Morgan Stanley
Box has large, attractive market opportunity, says Morgan Stanley
LH LabCorp
$248.44 /

+4.32 (+1.77%)

02/12/21 JPMorgan
LabCorp price target raised to $279 from $261 at JPMorgan
02/12/21 Mizuho
LabCorp price target raised to $267 from $242 at Mizuho
02/12/21 Citi
LabCorp price target raised to $278 from $257 at Citi
01/29/21 Citi
LabCorp price target raised to $257 from $249 at Citi
ZI ZoomInfo
$55.19 /

+3.875 (+7.55%)

SPR Spirit AeroSystems
$41.85 /

-0.91 (-2.13%)

PAVM PAVmed
$4.34 /

-1.2 (-21.66%)

NLS Nautilus
$22.00 /

-4.61 (-17.32%)

NKLA Nikola
$19.19 /

-1.72 (-8.23%)

M Macy's
$15.53 /

+0.25 (+1.64%)

LH LabCorp
$248.44 /

+4.32 (+1.77%)

HD Home Depot
$262.96 /

-12.87 (-4.67%)

FI Frank's International
$4.35 /

+0.88 (+25.36%)

FB Facebook
$262.57 /

+2.22 (+0.85%)

BOX Box
$18.53 /

+0.925 (+5.25%)

AMC AMC Entertainment
$7.56 /

+1.03 (+15.77%)

  • 23
    Feb
  • 02
    Dec
  • 20
    Aug
  • 22
    Jul
  • 04
    Jun
PSTH Pershing Square Tontine Holdings
$28.30 /

-1.15 (-3.90%)

NLS Nautilus
$22.00 /

-4.61 (-17.32%)

NKLA Nikola
$19.19 /

-1.72 (-8.23%)

M Macy's
$15.53 /

+0.25 (+1.64%)

LH LabCorp
$248.44 /

+4.32 (+1.77%)

HD Home Depot
$262.96 /

-12.87 (-4.67%)

FTOC FTAC Olympus Acquisition
$11.80 /

-0.8 (-6.35%)

FSR Fisker
$16.50 /

-1.65 (-9.09%)

FB Facebook
$262.57 /

+2.22 (+0.85%)

CCIV Churchill Capital Corp IV
$38.10 /

-19.3 (-33.62%)

BOX Box
$18.53 /

+0.925 (+5.25%)

BFT Foley Trasimene Acquisition Corp. II
$15.78 /

-1.14 (-6.74%)

AMC AMC Entertainment
$7.56 /

+1.03 (+15.77%)

ZI ZoomInfo
$55.19 /

+3.875 (+7.55%)

SPR Spirit AeroSystems
$41.85 /

-0.91 (-2.13%)

RTP Reinvent Technology Partners
$13.10 /

-1.52 (-10.40%)

NLS Nautilus
$22.00 /

-4.61 (-17.32%)

NKLA Nikola
$19.19 /

-1.72 (-8.23%)

M Macy's
$15.53 /

+0.25 (+1.64%)

LH LabCorp
$248.44 /

+4.32 (+1.77%)

HD Home Depot
$262.96 /

-12.87 (-4.67%)

FTOC FTAC Olympus Acquisition
$11.80 /

-0.8 (-6.35%)

FSR Fisker
$16.50 /

-1.65 (-9.09%)

FB Facebook
$262.57 /

+2.22 (+0.85%)

CCIV Churchill Capital Corp IV
$38.10 /

-19.3 (-33.62%)

BOX Box
$18.53 /

+0.925 (+5.25%)

BFT Foley Trasimene Acquisition Corp. II
$15.78 /

-1.14 (-6.74%)

AMC AMC Entertainment
$7.56 /

+1.03 (+15.77%)

ZI ZoomInfo
$55.19 /

+3.875 (+7.55%)

SPR Spirit AeroSystems
$41.85 /

-0.91 (-2.13%)

PSTH Pershing Square Tontine Holdings
$28.30 /

-1.15 (-3.90%)

NLS Nautilus
$22.00 /

-4.61 (-17.32%)

NKLA Nikola
$19.19 /

-1.72 (-8.23%)

M Macy's
$15.53 /

+0.25 (+1.64%)

LH LabCorp
$248.44 /

+4.32 (+1.77%)

HD Home Depot
$262.96 /

-12.87 (-4.67%)

FTOC FTAC Olympus Acquisition
$11.80 /

-0.8 (-6.35%)

FSR Fisker
$16.50 /

-1.65 (-9.09%)

FB Facebook
$262.57 /

+2.22 (+0.85%)

CIIC CIIG Merger
$23.60 /

-2.54 (-9.72%)

CCIV Churchill Capital Corp IV
$38.10 /

-19.3 (-33.62%)

BOX Box
$18.53 /

+0.925 (+5.25%)

BFT Foley Trasimene Acquisition Corp. II
$15.78 /

-1.14 (-6.74%)

AMC AMC Entertainment
$7.56 /

+1.03 (+15.77%)

Hot Stocks
Facebook to restore news access on its platform in Australia » 06:09
02/23/21
02/23
06:09
02/23/21
06:09
FB

Facebook

$260.34 /

-1.31 (-0.50%)

Facebook will restore…

Facebook will restore news access on its platform in Australia following negotiations, saying in an update to changes made last week: "We're pleased that we've been able to reach an agreement with the Australian government and appreciate the constructive discussions we've had with Treasurer Frydenberg and Minister Fletcher over the past week. We have consistently supported a framework that would encourage innovation and collaboration between online platforms and publishers. After further discussions, we are satisfied that the Australian government has agreed to a number of changes and guarantees that address our core concerns about allowing commercial deals that recognize the value our platform provides to publishers relative to the value we receive from them. As a result of these changes, we can now work to further our investment in public interest journalism and restore news on Facebook for Australians in the coming days." Reference Link

ShowHide Related Items >><<
FB Facebook
$260.34 /

-1.31 (-0.50%)

FB Facebook
$260.34 /

-1.31 (-0.50%)

02/16/21 Loop Capital
Facebook price target raised to $370 from $330 at Loop Capital
02/10/21 Tigress Financial
Facebook has 'significant upside' at current levels, says Tigress
02/01/21 Truist
Alphabet price target raised to $2,100 from $2,000 at Truist
01/31/21 Citi
Facebook price target raised to $320 from $315 at Citi
FB Facebook
$260.34 /

-1.31 (-0.50%)

FB Facebook
$260.34 /

-1.31 (-0.50%)

FB Facebook
$260.34 /

-1.31 (-0.50%)

FB Facebook
$260.34 /

-1.31 (-0.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.